CXC chemokine ligand 16 in periodontal diseases: Expression in diseased tissues and production by cytokine-stimulated human gingival fibroblasts

Clinical and Experimental Immunology

Volumn 149, Issue 1, 2007, Pages 146-154

  Hosokawa, Y ^a   Hosokawa, I ^a   Ozaki, K ^a   Nakae, H ^a   Matsuo, T ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

CXCL16; CXCR6; Human gingival fibroblasts; Periodontal disease

Indexed keywords

ADAM PROTEIN; CHEMOKINE RECEPTOR CXCR6; CXCL16 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; MESSENGER RNA; PROTEIN; PROTEIN ADAM 10; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FIBROBLAST; GENE EXPRESSION; GINGIVA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PERIODONTAL DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; CELLS, CULTURED; CHEMOKINES, CXC; CHRONIC DISEASE; CYTOKINES; FEMALE; FIBROBLASTS; GENE EXPRESSION; GINGIVA; HUMANS; INTERFERON TYPE II; INTERLEUKIN-13; INTERLEUKIN-1BETA; INTERLEUKIN-4; MALE; METALLOPROTEASES; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; PERIODONTITIS; RECEPTORS, CHEMOKINE; RECEPTORS, SCAVENGER; RECEPTORS, VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 34250175854     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03398.x     Document Type: Article

References (47)

1. Dzink JL, Tanner AC, Haffajee AD, Socransky SS. Gram negative species associated with active destructive periodontal lesions. J Clin Periodontol 1985 12 : 648 59.
2. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol 1998 25 : 134 44.
3. Kjeldsen M, Holmstrup P, Bendtzen K. Marginal periodontitis and cytokines: a review of the literature. J Periodontol 1993 64 : 1013 22.
4. Wilson M, Reddi K, Henderson B. Cytokine-inducing components of periodontopathogenic bacteria. J Periodont Res 1996 31 : 393 407.
5. Taubman MA, Valverde P, Han X, Kawai T. Immune response: the key to bone resorption in periodontal disease. J Periodontol 2005 76 : 2033 41.
6. Jotwani R, Cutler CW. Multiple dendritic cell (DC) subpopulations in human gingiva and association of mature DCs with CD4+ T-cells in situ. J Dent Res 2003 82 : 736 41.
7. Taubman MA, Kawai T. Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Crit Rev Oral Biol Med 2001 12 : 125 35.
8. Seymour GJ, Gemmell E, Reinhardt RA, Eastcott J, Taubman MA. Immunopathogenesis of chronic inflammatory periodontal diseases: cellular and molecular mechanisms. J Periodont Res 1993 28 : 478 86.
9. Taubman MA, Haffajee AD, Socransky SS, Smith DJ, Ebersole JL. Longitudinal monitoring of human antibody in subjects with destructive periodontal diseases. J Periodont Res 1992 27 : 511 21.
10. Kawai T, Eisen-Lev R, Seki M, Eastcott J, Wilson ME, Taubman MA. Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease. J Immunol 2000 164 : 2102 9.
11. Hosokawa Y, Nakanishi T, Yamaguchi D et al. Macrophage inflammatory protein 3alpha-CC chemokine receptor 6 interactions play an important role in CD4+ T-cell accumulation in periodontal diseased tissue. Clin Exp Immunol 2002 128 : 548 54.
12. Hosokawa Y, Nakanishi T, Yamaguchi D, Nakae H, Matsuo T. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in periodontal diseased tissue. Clin Exp Immunol 2005 139 : 506 12.
13. Hosokawa Y, Hosokawa I, Ozaki K et al. CXCL12 and CXCR4 expression by human gingival fibroblasts in periodontal disease. Clin Exp Immunol 2005 141 : 467 74.
14. Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Matsuo T. Increase of CCL20 expression by human gingival fibroblasts upon stimulation with cytokines and bacterial endotoxin. Clin Exp Immunol 2005 142 : 285 91.
15. Yoshie O, Imai T, Nomiyama H. Chemokines in immunity. Adv Immunol 2001 78 : 57 110.
16. Bazan JF, Bacon KB, Hardiman G et al. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997 385 : 640 4.
17. Pan Y, Lloyd C, Zhou H et al. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 1997 387 : 611 7.
18. Matloubian M, David A, Engel S, Ryan JE, Cyster JG. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 2000 1 : 298 304.
19. Wilbanks A, Zondlo SC, Murphy K et al. Expression cloning of the STRL33/BONZO/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokines. J Immunol 2001 166 : 5145 54.
20. Shimaoka T, Nakayama T, Fukumoto N et al. Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells. J Leukoc Biol 2004 75 : 267 74.
21. Gough PJ, Garton KJ, Wille PT, Rychlewski M, Dempsey PJ, Raines EW. A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16. J Immunol 2004 172 : 3678 85.
22. Abel S, Hundhausen C, Mentlein R et al. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J Immunol 2004 172 : 6362 72.
23. Ludwig A, Schulte A, Schnack C et al. Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells. J Neurochem 2005 93 : 1293 303.
24. Shimaoka T, Kume N, Minami M et al. Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J Biol Chem 2000 275 : 40663 6.
25. Shashkin P, Simpson D, Mishin V, Chesnutt B, Ley K. Expression of CXCL16 in human T cells. Arterioscler Thromb Vasc Biol 2003 23 : 148 9.
26. Hofnagel O, Luechtenborg B, Plenz G, Robenek H. Expression of the novel scavenger receptor SR-PSOX in cultured aortic smooth muscle cells and umbilical endothelial cells. Arterioscler Thromb Vasc Biol 2002 22 : 710 1.
27. Kim CH, Kunkel EJ, Boisvert J et al. Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. J Clin Invest 2001 107 : 595 601.
28. Motsinger A, Haas DW, Stanic AK, Van Kaer L, Joyce S, Unutmaz D. CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection. J Exp Med 2002 195 : 869 79.
29. Thomas SY, Hou R, Boyson JE et al. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J Immunol 2003 171 : 2571 80.
30. Sharron M, Pohlmann S, Price K et al. Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes. Blood 2000 96 : 41 9.
31. Minami M, Kume N, Shimaoka T et al. Expression of SR-PSOX, a novel cell-surface scavenger receptor for phosphatidylserine and oxidized LDL in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2001 21 : 1796 800.
32. Wuttge DM, Zhou X, Sheikine Y et al. CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2004 24 : 750 5.
33. Yamauchi R, Tanaka M, Kume N et al. Upregulation of SR-PSOX/CXCL16 and recruitment of CD8+ T cells in cardiac valves during inflammatory valvular heart disease. Arterioscler Thromb Vasc Biol 2004 24 : 282 7.
34. Fukumoto N, Shimaoka T, Fujimura H et al. Critical roles of CXC chemokine ligand 16/scavenger receptor that binds phosphatidylserine and oxidized lipoprotein in the pathogenesis of both acute and adoptive transfer experimental autoimmune encephalomyelitis. J Immunol 2004 173 : 1620 7.
35. Nanki T, Shimaoka T, Hayashida K, Taniguchi K, Yonehara S, Miyasaka N. Pathogenic role of CXCL16-CXCR6 pathway in rheumatoid arthritis. Arthritis Rheum 2005 52 : 3004 14.
36. Amanuma R, Nakajima T, Yoshie H, Yamazaki K. Increased infiltration of CD1d and natural killer T cells in periodontal disease tissues. J Periodont Res 2006 41 : 73 9.
37. Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 2000 18 : 593 620.
38. Inngjerdingen M, Damaj B, Maghazachi AA. Expression and regulation of chemokine receptors in human natural killer cells. Blood 2001 97 : 367 75.
39. Hanazawa S, Kawata Y, Takeshita A et al. Expression of monocyte chemoattractant protein 1 (MCP-1) in adult periodontal disease. increased monocyte chemotactic activity in crevicular fluids and induction of MCP-1 expression in gingival tissues. Infect Immun 1993 61 : 5219 24.
40. Gemmell E, Carter CL, Seymour GJ. Chemokines in human periodontal disease tissues. Clin Exp Immunol 2001 125 : 134 41.
41. Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A. Levels of interleukin-1 beta-8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment. J Periodontol 2000 71 : 1535 45.
42. Chandrasekar B, Mummidi S, Valente AJ et al. The pro-atherogenic cytokine interleukin-18 induces CXCL16 expression in rat aortic smooth muscle cells via MyD88, interleukin-1 receptor-associated kinase, tumor necrosis factor receptor-associated factor 6, c-Src, phosphatidylinositol 3-kinase, Akt, c-Jun N-terminal kinase, and activator protein-1 signaling. J Biol Chem 2005 280 : 26263 77.
43. Garton KJ, Gough PJ, Blobel CP et al. Tumor necrosis factor-alpha- converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem 2001 276 : 37993 8001.
44. Hundhausen C, Misztela D, Berkhout TA et al. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 2003 102 : 1186 95.
45. Zheng Y, Saftig P, Hartmann D, Blobel C. Evaluation of the contribution of different ADAMs to tumor necrosis factor alpha (TNFalpha) shedding and of the function of the TNFalpha ectodomain in ensuring selective stimulated shedding by the TNFalpha convertase (TACE/ADAM17). J Biol Chem 2004 279 : 42898 906.
46. Tsakadze NL, Sithu SD, Sen U, English WR, Murphy G, D'Souza SE. Tumor necrosis factor-alpha-converting enzyme (TACE/ADAM-17) mediates the ectodomain cleavage of intercellular adhesion molecule-1 (ICAM-1). J Biol Chem 2006 281 : 3157 64.
47. Pan B, Farrugia AN, To LB et al. The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE). J Bone Miner Res 2004 19 : 147 54.